Local
Common osteoporosis drugs linked to 24% lower dementia risk in major study
A Roundtable is a way to meet new people and discuss this article in person at a local coffee shop or other venue.
Roundtables are designed for groups of four, with a shared subject and room for everyone to speak. Come for discussion, with no dating expectation.
Source: The Stute

Osteoporosis drugs are often given to prevent bone loss and reduce bone fractures. However, these drugs also have another interesting effect. Specific osteoporosis drugs contain specific compounds known as nitrogen-containing bisphosphonates (NBPs). These compounds sever the ability of osteoclasts (cells that break down mineralized bone) to function. A recent study by the University of Hong Kong Li Ka Shing Faculty of Medicine (HKUMed) took 121,492 adults above the age of sixty, all of whom had osteoporosis or “fragility fractures,” which are breaks in bones that occur after they have already weakened. Records covered the period between 2005 and 2020. After participants took these drugs, HKUMed researchers found that adults taking osteoporosis drugs with NBPs were actually 16% less likely to develop Alzheimer’s disease and Alzheimer’s Disease Related Dementias (ADRDs) than those taking no medication.
This excerpt comes from the named source. Read the original for the full reporting.
Read the original at The Stute



